Career history of Jeffrey Fryer
Former positions of Jeffrey Fryer
| Companies | Position | Start | End |
|---|---|---|---|
| RALLYBIO CORPORATION | Director of Finance/CFO | 2017-12-31 | 2023-01-31 |
| Founder | 2017-12-31 | 2023-01-31 | |
| Treasurer | 2017-12-31 | 2023-01-31 | |
| ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2008-03-31 | 2017-03-31 |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Founder | 2017-12-31 | - |
Training of Jeffrey Fryer
| University of Hartford | Graduate Degree |
| Bryant University | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Founder | 2 |
| Director of Finance/CFO | 1 |
| Treasurer | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Commercial Services |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Fryer
- Experience
